STSS Sharps Technology Inc. Insider Trading

FalconX Holdings Ltd liquidates entire 769.3K share stake in STSS for $1,490,755.32 via 4 sales at $1.93–$1.97 (Jan 9–12); stock now -98.9% from 52-week high.

FalconX Holdings Ltd, a 10% owner, executed 4 separate sales totaling 769,320 shares for $1,490,755.32 between January 9–12, 2026, completely exiting its position at a blended average price of $1.94. The timing coincides with extreme price deterioration: STSS is trading at $1.76, down 19.3% over 30 days and 42.9% over 90 days, positioned 98.9% below its 52-week high of $155.79. Fundamental deterioration is severe: the company posted $83.6K in quarterly revenue against a $-105.3M net loss, with a market cap of $49.7M and trailing unprofitability. The complete liquidation of the 10% stake during a period of sustained stock weakness and operational distress warrants close examination of whether this reflects deteriorating confidence in recovery or visibility into future performance.

Director Simpson buys 20,000 STSS shares at $6.41 ($128.2K); 6-insider cluster buy; stock at $9.73, up 59% in 30 days.

Simpson Brenda Baird, as a director, purchased 20,000 shares at $6.41, establishing an initial position in Sharps Technology. This transaction is part of a cluster pattern in which 6 other insiders also bought within the past 14 days, indicating coordinated accumulation at the same price level. The stock has appreciated significantly from the $6.41 transaction price to $9.73 currently (+59.0% in 30 days), though it trades -99.5% from its 52-week high of $2013.00. The company's fundamentals remain volatile: it generated $3.6M in net income this quarter but was unprofitable over its most recent full fiscal year, with quarterly revenue of only $222.7K and market cap of $10.0M. The scale of insider accumulation simultaneous with steep recent price recovery warrants examination of whether these purchases reflect informed confidence or occur amid broader price momentum.

Director Hayes buys 100.0K shares at $6.41; stock now $9.73. Prior 5 STSS buys all well-timed; cluster of 6 others buying within 14 days.

Director Robert Michael Hayes purchased 100,000 shares at $6.41 on 2025-08-22, establishing a new full position in Sharps Technology Inc. This transaction is notable because Hayes has executed 5 prior buys at this same ticker, with all 5 demonstrating strong 90-day returns (ranging from +3,755.6% to +18,600.0%), establishing a pattern of well-timed entry points. The current $9.73 price reflects a 51.6% gain from his transaction price, while his prior STSS purchases exhibited 90-day win rates of 100%. Simultaneously, 6 other insiders have made purchases within the past 14 days, forming a coordinated cluster buy pattern. However, the company's fundamentals present tension with this insider confidence: while net income is positive at $3.6M in the latest quarter, the company was unprofitable over its most recent full fiscal year and shows minimal scale (revenue of $222.7K quarterly and market cap of $10.0M). The stock has also fallen -99.5% from its 52-week high of $2013.00, suggesting either extreme volatility or a significant prior spike that has largely reversed.

Director Christiansen buys 80.0K shares of STSS at $6.41; 6 other insiders bought within 14 days.

Christiansen Soren Bo (Director) purchased 80,000 shares at $6.41 on 2025-08-22, establishing a new 80,000-share position. This transaction is part of a cluster pattern—6 other insiders also bought within the past 14 days—suggesting coordinated insider accumulation. The stock is currently at $9.73, trading -99.5% from its 52-week high of $2013.00, with strong recent momentum (+59.0% over 30 days, +156.0% over 90 days). However, the company reported only $222.7K revenue in its latest quarter against a $10.0M market cap, and was unprofitable over its most recent full fiscal year despite posting $3.6M net income in the quarter—a significant structural concern. The cluster purchase at this price point, combined with extreme volatility and profitability questions, warrants detailed assessment of company fundamentals and insider motivations.

Director Ruemler buys 40,000 shares for $454,301.42 at STSS, his largest purchase; 6 insiders bought in 14 days.

Director Timothy James Ruemler purchased 40,000 shares across 11 separate transactions on 2025-08-25 for a combined $454,301.42, at a blended average price of $11.36—a substantial increase from his pre-transaction holding of 218 shares to 40,218 shares (+18348.6%). This filing arrives amid a marked cluster pattern: 6 other insiders also bought within the past 14 days at STSS. Notably, Ruemler's prior trades at STSS show a consistent pattern of well-timed buys, with all 5 prior purchases recording positive 90-day returns ranging from +479780.5% to +676400.0%. The company's financial position is mixed: latest quarterly revenue stands at $222,722.00 with net income of $3,559,307.00, but full-year results were unprofitable. The current market price of $9.73 sits -99.5% from the 52-week high of $2,013.00, and the stock has appreciated +59.0% over the past 30 days and +156.0% over the past 90 days. This combination of a substantial director purchase, corroborating insider activity, a historical pattern of well-timed buys at this specific ticker, and dramatic recent price recovery warrants investor attention.

Director Paul K. Danner bought 400,000 shares of Sharps Technology (STSS) at $6.41 for $2,564,000.00; stock now $9.73 (+51.5% YTD) but -99.5% from 52-week high of $2013.00.

Director Danner purchased 400.0K shares at $6.41 on 2025-08-22 for $2,564,000.00, representing his first open-market purchase at STSS. The stock has rebounded 59.0% over the past 30 days and 156.0% over 90 days, but remains 99.5% below its 52-week high of $2013.00, suggesting either a historical bubble, corporate restructuring, or pricing anomaly. Danner's prior cross-ticker buy (at an unspecified different stock) yielded a -74.4% average 30-day return, and this same ticker shows a comparable -74.4% 30-day outcome from his prior purchase on 2025-07-15, establishing a pattern of unfavorable near-term timing in his purchases. Critically, the company reported revenue of $222.7K against a market cap of $10.0M in the latest quarter, with an unprofitable full fiscal year, raising fundamental questions about sustainability; additionally, 6 other insiders also bought within the past 14 days, creating a cluster buy pattern that may reflect coordinated response to distressed valuation rather than isolated conviction.

CFO Crescenzo buys 40.0K shares at $6.41; stock up 59.0% in 30 days with 6-insider cluster buy pattern

Crescenzo Andrew R., CFO of Sharps Technology, purchased 40,000 shares at $6.41 on 2025-08-22, establishing an initial position. The stock has appreciated 59.0% over the past 30 days and 156.0% over 90 days, and this buy occurs within a cluster of 6 other insider purchases in the past 14 days—a pattern typically associated with concentrated conviction at a specific price point. Notably, Crescenzo's prior buy at STSS on 2023-12-28 delivered 90-day returns of 540924.7%, reflecting a pattern of well-timed entries at this ticker. However, the company's fundamentals present a mixed picture: it reported net income of $3.6M in the latest quarter but was unprofitable over its most recent full fiscal year, and the stock's 52-week performance shows a -99.5% decline from its high of $2013.00. The combination of strong recent price momentum, coordinated insider buying, and this insider's historical timing precision at STSS must be weighed against the company's precarious profitability profile.

Director Monroe Jason L. buys 80,000 shares of STSS at $6.41; 6 insiders buying in 14 days amid stock down 99.5% from $2013.00 high.

Monroe Jason L., a director, purchased 80,000 shares at $6.41 on 2025-08-22, establishing an initial position in Sharps Technology Inc. This transaction is part of a cluster pattern: 6 other insiders also bought within the past 14 days. The stock has declined 99.5% from its 52-week high of $2013.00, though it has recovered 59.0% over the past 30 days and 156.0% over 90 days. The company is currently profitable on a quarterly basis (net income $3.6M on revenue $222.7K) but was unprofitable over its most recent full fiscal year, raising questions about the sustainability of recent improvements. The coordinated buying activity by multiple insiders at depressed price levels warrants close attention to the company's operational trajectory and whether this represents accumulation based on forward catalysts or stabilization at a depressed valuation.

Director Paul K Danner buys 5 shares of STSS at $20.00; stock now $5.77, down 99.7% from 52-week high of $2031.48.

DANNER PAUL K, a director, purchased 5 shares at $20.00 on 2025-07-15, establishing an initial position of 5 shares. The current price of $5.77 represents a 71.2% decline from the transaction price, and the stock trades at -99.7% from its 52-week high of $2031.48, indicating severe deterioration in market value. The company reported negative net income over its most recent full fiscal year despite a market cap of $5,880,080.06, suggesting ongoing unprofitability. The magnitude of the buy signal is limited given the small share quantity and modest dollar amount of $100.00, but the extreme price collapse from the 52-week high warrants monitoring of whether the company's financial condition continues to deteriorate.

CEO Hayes buys 300,000 shares (300.0K shares) for $10,750.00 amid -99.8% decline from 52-week high

Robert Michael Hayes, Chief Executive Officer, completed 2 separate purchases totaling 300,000 shares (300.0K shares) for $10,750.00 between late February and March 2025, at prices of $0.04 and $0.03 per share, tripling his holdings from 100,882 to 400,882 shares. The timing is striking: the stock is currently trading at $8.19, down 99.8% from its 52-week high and off 90.4% in the past 30 days, yet Hayes is accumulating aggressively at depressed prices. His cross-ticker track record shows 17 prior open-market buys with a 100.0% 90-day win rate and an average 90-day return of +170416.7%, and at STSS specifically, all 5 of his prior buys exhibited strong 90-day positive returns, establishing a pattern of well-timed purchases at this ticker. Against this backdrop, the company is unprofitable (net income of $-1,685,060.00 over its most recent full fiscal year), which contextualizes why the stock has declined so sharply; however, Hayes's substantial insider accumulation at these levels suggests conviction in recovery potential.